A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)
Study Identifier
M13-093
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 1
Sex
Female
Age
18 - 65 Years
Protocol Summary
To assess the safety, tolerability and pharmacokinetics of ABT-199 in female subjects with Systemic Lupus Erythematosus.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 89694
Clearwater, Florida, United States, 33765
Status
Not applicable
Location
Site Reference ID/Investigator# 131720
DeBary, Florida, United States, 32713
Status
Not applicable
Location
Site Reference ID/Investigator# 118637
Miami, Florida, United States, 33136
Status
Not applicable
Location
Site Reference ID/Investigator# 124116
Miami Lakes, Florida, United States, 33016
Status
Not applicable
Location
Site Reference ID/Investigator# 89693
Orlando, Florida, United States, 32806
Status
Not applicable
Location
Site Reference ID/Investigator# 78256
Overland Park, Kansas, United States, 66212
Status
Not applicable
Showing {first} - {last} of {total} Results